bf/NASDAQ:RLMD_icon.png

COM:RELMADA

Relmada Therapeutics, Inc.

  • Stock

Last Close

2.85

21/11 21:00

Market Cap

128.54M

Beta: -

Volume Today

250.57K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '15
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
gross profit
selling and marketing expenses
12.31M
-
general and administrative expenses
9.23M
-
9.23M
0%
10.01M
8.48%
5.93M
40.80%
3.97M
32.92%
5.70M
43.48%
24.87M
336.00%
35.08M
41.08%
47.93M
36.61%
36.59M
23.66%
selling general and administrative expenses
9.23M
-
9.23M
0%
10.01M
8.48%
5.93M
40.80%
3.97M
32.92%
5.70M
43.48%
24.87M
336.00%
35.08M
41.08%
47.93M
36.61%
48.89M
2.02%
research and development expenses
7.87M
-
7.87M
0%
6.21M
21.16%
1.29M
79.16%
2.94M
127.49%
7.02M
138.72%
35.97M
412.09%
90.62M
151.92%
113.32M
25.05%
54.81M
51.64%
other expenses
130.27K
-
216.21K
65.97%
2.35K
98.91%
6.35M
-
cost and expenses
17.10M
-
17.10M
0%
16.22M
5.17%
7.22M
55.48%
6.92M
4.17%
12.73M
84.00%
60.84M
377.99%
125.70M
106.62%
161.25M
28.28%
103.70M
35.69%
operating expenses
17.10M
-
17.10M
0%
16.22M
5.17%
7.22M
55.48%
6.92M
4.17%
12.73M
84.00%
60.84M
377.99%
125.70M
106.62%
161.25M
28.28%
103.70M
35.69%
interest expense
4.92K
-
4.92K
0%
1.34M
-
-4.21M
-
ebitda
-13.38M
-
-17.08M
27.65%
-29.27M
71.38%
-7.85M
73.18%
-6.21M
20.95%
-8.89M
43.31%
-60.82M
583.86%
-124.46M
104.62%
-156.44M
25.70%
-103.70M
33.71%
operating income
-17.10M
-
-17.10M
0%
-16.22M
5.17%
-7.22M
55.48%
-6.92M
4.17%
-12.73M
84.00%
-60.84M
377.99%
-125.70M
106.62%
-161.25M
28.28%
-103.70M
35.69%
depreciation and amortization
9.26K
-
9.26K
0%
54.82K
492.25%
85.27K
55.55%
2.63K
96.92%
4.87K
85.38%
16.95K
247.97%
1.25M
7,260.99%
4.81M
285.27%
total other income expenses net
-3.71M
-
-3.71M
0%
13.24M
456.82%
932.86K
92.95%
-706.55K
175.74%
-3.83M
441.94%
1.38M
136.10%
-48.32K
103.50%
4.21M
8,803.46%
4.91M
16.77%
income before tax
-20.80M
-
-20.80M
0%
-2.97M
85.70%
-6.29M
111.33%
-8.96M
42.54%
-17.32M
93.26%
-59.46M
243.32%
-125.75M
111.50%
-157.04M
24.88%
-98.79M
37.09%
income tax expense
3.70M
-
4.92K
99.87%
-13.11M
266,467.59%
-716.10K
94.54%
630.27K
188.01%
-3.83M
707.53%
-1.39M
63.80%
47.06K
103.40%
-4.21M
9,036.13%
net income
-20.80M
-
-20.80M
0%
-2.97M
85.70%
-6.29M
111.33%
-8.96M
42.54%
-17.32M
93.26%
-58.07M
235.32%
-125.80M
116.63%
-152.84M
21.49%
-98.79M
35.36%
weighted average shs out
2.49M
-
2.49M
0%
2.90M
16.68%
3.02M
4.10%
3.14M
3.90%
6.31M
101.25%
15.59M
147.07%
17.55M
12.56%
29.63M
68.80%
30.10M
1.59%
weighted average shs out dil
2.49M
-
2.49M
0%
2.90M
16.68%
3.02M
4.10%
3.14M
3.90%
6.31M
101.25%
15.59M
147.07%
17.55M
12.56%
29.63M
68.80%
30.10M
1.59%
eps
-8.37
-
-8.37
0%
-1.03
87.69%
-2.08
101.94%
-2.86
37.50%
-2.74
4.20%
-3.72
35.77%
-7.17
92.74%
-5.16
28.03%
-3.28
36.43%
epsdiluted
-8.37
-
-8.37
0%
-1.03
87.69%
-2.08
101.94%
-2.86
37.50%
-2.74
4.20%
-3.72
35.77%
-7.17
92.74%
-5.16
28.03%
-3.28
36.43%

All numbers in (except ratios and percentages)